Thiazolyl Blue cation | 13146-93-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: Thiazolyl Blue cation
• 英文别名: 2-(3,5-diphenyltetrazol-2-ium-2-yl)-4,5-dimethyl-1,3-thiazole
• CAS: 13146-93-5
• 化学式: C18H16N5S+
• 分子量: 334.4
• InChiKey: FTZIQBGFCYJWKA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  75.7
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] THIOSEMICARBAZONE COMPOUNDS AND USE THEREOF<br/>[FR] COMPOSÉS THIOSEMICARBAZONES ET LEUR UTILISATION
  申请人：RICHARDSON DESI RAYMOND

  公开号：WO2010000008A1

  公开（公告）日：2010-01-07

  A method of treating a proliferative disease in a vertebrate, the method comprising administering to the vertebrate a therapeutically effective amount of at least one compound of formula (I) (I) wherein R1 is selected from H, C1-6 alkyl, C2-6 alkenyl and phenyl; R2 is selected from H, C1-6 alkyl, C2-6 alkenyl and phenyl; wherein R1 and R2 are the same or different, or a salt, hydrate, or iron complex thereof, or a pharmaceutical composition comprising said compound, salt, hydrate or iron complex and a pharmaceutically acceptable carrier, diluent or excipient.

  在脊椎动物中治疗增生性疾病的方法，该方法包括向脊椎动物施用至少一种式(I)的化合物的治疗有效量(I)其中R1从H，C1-6烷基，C2-6烯基和苯基中选择；R2从H，C1-6烷基，C2-6烯基和苯基中选择；其中R1和R2相同或不同，或其盐，水合物或铁络合物，或包括所述化合物，盐，水合物或铁络合物以及药学上可接受的载体，稀释剂或赋形剂的药物组合物。
• 2-[3H-THIAZOL-2-YLIDINEMETHYL]PYRIDINES AND RELATED COMPOUNDS AND THEIR USE
  申请人：Brown Robert

  公开号：US20090247579A1

  公开（公告）日：2009-10-01

  The present invention pertains to certain 2-[3H-thiazol-2-ylidinemethyl]pyridine compounds and analogs thereof, which, inter alia, inhibit cell proliferation, treat cancer, etc., and more specifically to compounds of the following formula, wherein R A1 , R A2 , R A3 , R A4 , R B1 , R B2 , R NA , R NB , and X − are as defined herein: The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit cell proliferation, and in the treatment of proliferative conditions such as cancer, etc.

  本发明涉及某些2-[3H-噻唑-2-基亚甲基]吡啶化合物及其类似物，其中包括抑制细胞增殖、治疗癌症等作用，更具体地涉及以下式的化合物，其中R A1 、R A2 、R A3 、R A4 、R B1 、R B2 、R NA 、R NB 和X − 如本文所定义： 本发明还涉及包含这种化合物的药物组合物，以及在体外和体内使用这种化合物和组合物来抑制细胞增殖，并用于治疗癌症等增生性疾病。
• [EN] CONJUGATES OF THE B-SUBUNIT OF SHIGA TOXIN FOR ANTICANCER THERAPIES<br/>[FR] CONJUGUÉS DE LA SOUS-UNITÉ B DE TOXINE DE SHIGA POUR DES THÉRAPIES ANTICANCÉREUSES
  申请人：INST CURIE

  公开号：WO2014086952A1

  公开（公告）日：2014-06-12

  Conjugates or pharmaceutical compositions comprising conjugates of the B-subunit of Shiga toxin that are useful for cancer therapies are disclosed. More specifically, the pharmaceutical compositions comprise STxB conjugated to at least one antimitotic agent such as auristatin or pharmaceutically acceptable salts thereof through a bifunctional linker. Processes to make the conjugates, as well as methods to treat cancers are also disclosed.

  披露了用于癌症治疗的志贺毒素B亚单位偶联物或药物组合物。更具体地说，药物组合物包含通过双功能连接剂与至少一种抗有丝分裂剂如auriSTatin或药用可接受盐偶联的STxB。还披露了制造偶联物的方法以及治疗癌症的方法。
• PYRAZOLE DERIVATIVES AS P38 MAP INHIBITORS
  申请人：RESPIVERT LIMITED

  公开号：US20150203475A1

  公开（公告）日：2015-07-23

  Compounds of formula (I): wherein R 1 , R 2 , J, Q, V, X, Y and Z are defined herein are disclosed. The compounds are inhibitors of the family of p38 mitogen-activated protein kinase enzymes (referred to herein as p38 MAP kinase inhibitors), particularly the alpha sub-type thereof, and of Syk kinase and the Src family of tyrosine kinases. The compounds may be used in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, in particular inflammatory diseases of the lung, such as asthma and COPD, as well as those of the gastrointestinal tract, such as ulcerative colitis and Crohn's disease and of the eye, such as uveitis.

  式(I)的化合物： 其中R1、R2、J、Q、V、X、Y和Z的定义如本文所述。这些化合物是p38丝裂原活化蛋白激酶酶家族（以下简称为p38 MAP激酶抑制剂）的抑制剂，特别是其α亚型，以及Syk激酶和Src酪氨酸激酶家族的抑制剂。这些化合物可用于治疗，包括在药物组合中，特别是用于治疗炎症性疾病，特别是肺部的炎症性疾病，如哮喘和COPD，以及胃肠道的炎症性疾病，如溃疡性结肠炎和克罗恩病，以及眼部的炎症性疾病，如葡萄膜炎。
• [EN] THERAPEUTIC COMPOUNDS<br/>[FR] COMPOSÉS THÉRAPEUTIQUES
  申请人：UNIV IOWA RES FOUND

  公开号：WO2014018765A1

  公开（公告）日：2014-01-30

  The invention provides compounds useful as anti-cancer agents.

  这项发明提供了作为抗癌药物有用的化合物。

表征谱图